Recent Press Releases

Abbott Hosts Conference Call for First-Quarter Earnings

ABBOTT PARK, Ill., April 1, 2014 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its first-quarter 2014 financial results on

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

- Timely collaborations underscore ViiV Healthcare's commitment to increase access to life-saving HIV medicines for children and adults in the developing world

Eli Lilly and Company Expands Authorized Generic Agreements with Prasco®

- Prasco to market the Authorized Generic of EVISTA® in the United States

CINCINNATI, April 1, 2014

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool

ViiV Healthcare announces new initiatives to improve access to dolutegravir: licence to the Medicines Patent Pool - Timely collaborations underscore ViiV Healthcare's commitment to increase...

Actavis Acquires Silom Medical Company

Actavis Acquires Silom Medical Company - Establishes Leading Position in Fast-Growing Thai Pharmaceutical Market - Immediately Accretive to Non-GAAP Earnings - Enhances Actavis' Growth Platform...

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022 INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S. District...

Results from phase III patient preference study of GSK's Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology

Results from phase III patient preference study of GSK's Votrient® (pazopanib) vs. Sutent® (sunitinib) in advanced renal cell carcinoma published in Journal of Clinical Oncology Data from the...

Johnson & Johnson Announces Acceptance Of Binding Offer From The Carlyle Group To Acquire Ortho-Clinical Diagnostics

NEW BRUNSWICK, N.J., March 31, 2014 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) today announced that it

U.S. District Court Upholds Validity of Lilly's Alimta Patent Through 2022

INDIANAPOLIS, March 31, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) today announced that the U.S.

Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction

Mylan Comments on U.S. Supreme Court's Consideration of the Standard of Review of Patent Claim Construction PITTSBURGH, March 31, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) announced that...

Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent

Teva Announces U.S. Supreme Court Will Hear Its Appeal on COPAXONE® Patent JERUSALEM--(BUSINESS WIRE)--Mar. 31, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) today announced that the...

Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium(R) 24HR

Pfizer Statement on U.S. FDA Approval of Over-the-Counter Nexium(R) 24HR NEW YORK--(BUSINESS WIRE)--March 28, 2014-- Today the U.S. Food and Drug Administration (FDA) approved over-the-counter...

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth - Creates world's first R&D Open Lab to increase...

FDA approves Biogen Idec's Alprolix, the first hemophilia B therapy to reduce bleeding episodes with prophylactic infusions starting at least a week apart

FDA approves Biogen Idec's Alprolix, the first hemophilia B therapy to reduce bleeding episodes with prophylactic infusions starting at least a week apart Friday, March 28, 2014 6:24 pm EDT -Only...

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth

GSK announces new strategic investments in Africa to increase access to medicines, build capacity and deliver sustainable growth - Creates world's first R&D Open Lab to increase...

Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG

Clinigen Group Acquires Oncology Support Therapy SAVENE® (dexrazoxane) from SpePharm AG Acquisition strengthens Clinigen's position in dexrazoxane market Burton-on-Trent, UK...

Data From Phase 3 Pivotal Studies Show Amgen's Novel Investigational Cholesterol-Lowering Medication Evolocumab Significantly Reduced LDL Cholesterol In Statin Intolerant Patients And In Patients On Statins

Data From Two Separate Phase 3 Studies of Evolocumab (AMG 145), a PCSK9 Inhibitor, Presented in Late-Breaking Clinical Trials Session at ACC.14 - Data Add to the Three Pivotal Studies Presented Ye

GSK acquires full ownership of its Indonesian Consumer Healthcare business

GSK acquires full ownership of its Indonesian Consumer Healthcare business Issued: Friday 28 March 2014, London UK GlaxoSmithKline (GSK) has acquired full ownership of its Indonesian Consumer...

Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma

Roche's new time-saving subcutaneous formulation of MabThera approved in Europe for the treatment of common forms of non-Hodgkin Lymphoma MabThera SC offers a faster treatment experience for...